A multiplex polymerase chain reaction (PCR) was developed for the simultaneous detection of Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila. Oligonucleotide primers for the amplification of the DNA of these three organisms were optimized for use in combination in the same reaction. PCR products were detected by the Micro-Chip Electrophoresis Analysis System. Clinical samples were obtained from 208 community-acquired pneumonia (CAP) patients who were participants in a multicenter CAP surveillance study performed at seven medical schools and their affiliate hospitals in Japan. No significant differences in the sensitivity of each primer set were observed when tested in both the multiplex and monoplex PCR assays. Our multiplex PCR was able to reliably detect 10 copies/100 ml of each of the three pathogen DNAs. Of the panel of 208 samples, 14 of 15 C. pneumoniae, 10 of 10 M. pneumoniae, eight of eight L. pneumophila and 165 of 176 negative samples were correctly identified. Eleven cases who were the multiplex PCR positive and conventional method negative were observed. The PCR findings were of possible significance in at least four of these patients. Our multiplex PCR assay could potentially be used as a diagnostic and
Introduction
Atypical pathogens including Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila are an important cause of community-acquired pneumonia (CAP). Chlamydia pneumoniae and Mycoplasma pneumoniae are the most common pathogens in the outpatient setting and high incidences have been recorded in hospitalized patients with CAP. [1] [2] [3] L. peumophila has also been seen in the outpatient setting, 2,3 but this pathogen has been identified with the common organism in patients with CAP requiring the intensive care unit. 1 The incidence of infection with these atypical pathogens has been as high as 40-60% of all admitted patients, often as part of a mixed infection in Western countries. 4 In Japan, there have been some reports on the etiology of CAP among the Japanese population. [5] [6] [7] All these studies demonstrated that C. pneumoniae and M. pneumoniae are common pathogens, the third or fourth leading pathogens, and that the etiology of CAP in Japan does not differ significantly from that of Western countries.
Current methods for the identification of atypical pathogens include culturing, rapid antigen detection assays, serology and molecular techniques. Cell cultures for detection of C. pneumoniae require specialized laboratories and are expensive, time-consuming and labor-intensive. Since M. pneumoniae and L. pneumophila grow slowly and lack sensitivity, the clinical usefulness of cultures is limited. Rapid laboratory tests such as antigen detection or hybridization are of limited sensitivity. Serology usually requires documentation of a rise in antibody concentration from an acute phase serum sample to a convalescent phase serum sample, and thus, test results come in too late to be of relevance for the treatment of acute disease.
Currently available nucleic acid amplification (NAA) techniques, such as the polymerase chain reaction (PCR), are highly sensitive techniques for the rapid detection of nucleic acid sequences from viruses and bacteria in clinical specimens. These NAA techniques are particularly advantageous for the detection of fastidious or difficult to culture organisms such as atypical pathogens. Several conventional PCR assays have been developed and have demonstrated sensitivity and specificity equal to or even better than those of conventional microbiologic tests. 8, 9 More recently, multiplex PCR assays for the simultaneous detection of different pathogens have been developed. [10] [11] [12] [13] Here, we report on the development and evaluation of a multiplex PCR for the simultaneous detection of C. pneumoniae, M. pneumoniae and L. pneumophila in respiratory samples.
Subjects and methods

Origin of the samples
Nasopharyngeal swab specimens which were collected during a multicenter CAP surveillance study and stored at À201C were used in this study. A multicenter CAP surveillance study was performed in seven medical schools and their affiliate hospitals in Japan, including the University of the Ryukyus, Kagoshima University, Nagasaki University School of Medicine, Kurume University School of Medicine, Toho University School of Medicine, Tohoku University, Kawasaki Medical School and their affiliate hospitals between December 1999 and March 2000. The diagnosis was based on clinical signs and symptoms (cough, fever, productive sputum, dyspnea, chest pain, or abnormal breath sounds) and radiographic pulmonary abnormalities that were at least segmental and were due to preexisting or other known causes. Two hundred and thirty-nine CAP patients were enrolled in this study and eventually 208 patients (17-99 years of age; 120 males and 88 females) were analyzed.
Microbiologic laboratory tests
Blood cultures and nasopharyngeal swab specimens were obtained from 64% and 100% of the patients, respectively; when sputum was available, a Gram's stain test and a quantitative culture was obtained. Sputum data were only evaluated when the Gram's stain test revealed numerous leukocytes (425 in a 100 Â microscopic field) and few squamous epithelial cells (o10 in a 100 Â microscopic field). Certain invasive methods such as bronchoscopic examination were employed to obtain specimens in some patients after full explanation of the procedures. These specimens were also used for culturing of Legionella spp. on buffered charcoal-yeast extract alpha agar. Cultures for C. pneumoniae and C. psittaci were performed in cycloheximide-treated HEp-2 cells grown in a 24-well cell culture plate. 14 All specimens were passed twice. Culture confirmation was done by fluorescent-antibody staining with C. pneumoniae and C. psittaci species-specific and genus-specific monoclonal antibodies. 14 Paired serum samples were collected at intervals of at least 4 weeks and stored at À701C until testing. Complement fixation (CF) and passive agglutinin (PA) tests were used to detect antibodies to M. pneumoniae. Antibodies to Legionella spp. and Coxiella burnetii were measured by the indirect immunofluorescence test. The micro-immunofluorescence test was used for titration of IgG and IgM antibodies against Chlamydia spp. using formalinized elementary bodies of the C. pneumoniae TW-183 (purchased from the Washington Research Foundation, Seattle, WA, USA) and KKpn-15, 15 C. trachomatis L2/434/Bu and C. psittaci 6BC strains as antigens. Sera with IgM against Chlamydia spp. were retested after absorption with goat anti-human IgG antibody reagent (Gullsorb; Gull Laboratories, Salt Lake City, UT, USA) in order to exclude false-positive reactions. Antibodies to viruses such as influenza A and B viruses, adenovirus, respiratory syncytial virus, cytomegalovirus and parainfluenza virus types 1, 2 and 3 were measured at Kitasato-Otsuka virus assay laboratory. In addition to serology and culturing, the urinary antigen test was used for detection of L. pneumophila (NOW Legionella; Binax Inc., Portland, USA).
Criteria for determination of microbial etiology
Bacteria were considered to be definitive causative agents when isolated from blood culture. We considered the results of sputum cultures in combination with Gram's stain findings. An organism showing heavy (^10 7 colony-forming units [CFU]/ml) growth of a predominant bacterium on a sputum culture or moderate (10 5-6 CFU/ml) growth of a culture with phagocytosis observed by Gram's stain was considered to be a definitive pathogen. If an organism showing moderate growth of a predominant bacterium on a sputum culture without phagocytosis was observed by Gram's stain, that specimen was judged by the medical doctor according to clinical findings and course. If Legionella spp. was isolated from a specimen, that specimen was considered to be a definitive pathogen even if the culture showed little growth. L. pneumophila was considered to be a presumptive agent when the urinary antigen test result was positive. For serologic tests, a four-fold rise in the antibody titer level between paired sera was considered definitive. C. pneumoniae infection was defined as IgM^1:32 or a four-fold rise in IgG or IgM.
DNA extraction
A 1 ml aliquot of specimens was centrifuged at 15,000g for 10 min at room temperature. Most of the supernatant was discarded and 200 ml, including the pellets, were recovered and incubated with protenase K (20 ml) in AL buffer (200 ml, Qiagen) for 10 min at 561C. Subsequently, the samples were mixed with 100% ethanol (200 ml). The DNA was extracted using the Qiagen DNA mini kit (QIA amp, Qiagen) according to the manufacturer's recommendations. Then samples were treated with ethanol three times. DNA was eluted in a final volume of 200 ml, aliquoted, and stored at À201C before performance of the PCR.
Multiplex PCR
Target sequences were regions of the major outer membrane protein gene for C. pneumoniae (CPN 25: 5 0 -CTC GTT GGT TTA TTC GGA GTT AAA G-3 0 , CPN 26: 5 0 -GAG AAT TGC GAT ACG TTA CAG ATC A-3 0 ), the nucleotide sequence of the 16S rRNA for M. pneumoniae (MP 6: 5 0 -ATT GCC TTG GTA GGC CGT TAC CCC AC-3 0 , MP 8: 5 0 -CAA AGT TGA AAG GAC CTG CAA G-3 0 ) and the major outer membrane protein porin gene for L. pneumophila (LPN 15: 5 0 -AGT GCT TTG TTT GCA GGT ACG-3 0 , LPN 16: 5 0 -CAC CAA CAT CAG TAA AAC CAT TAT AGC-3 0 ). PCR reactions for these three pathogens were initially evaluated separately using serial dilutions of culture materials. The reactions were subsequently combined. Optimization of the multiplex assay was performed by testing different combinations of primer concentrations and magnesium concentrations, using a fixed dilution of the culture materials at about 2 log above the detection threshold of the individual assays, to establish a combination with the most comparable result. Finally, the reaction conditions of the multiplex PCR were 10 mM Tris-HCl, 50 mM KCl, 1.5 mM MgCl 2 , 5% dimethylsufoxide, 200 mM dNTPs, 5 U AmpliTaq DNA polymerase and the presence of concentrations (0.2-0.4 mM) of three primer pairs (Applied Biosystems). The PCR was performed in a Gene Amp PCR system 9600-R (Perkin-Elmer) with the following thermal profile: 10 min at 951C, followed by 40 cycles of 30 s at 941C, 30 s 601C and 60 s 721C and one cycle for 10 min at 721C. PCR product detection was performed with the Micro-Chip Electrophoresis Analysis System (SV1210 Cosmoeye, Hitachi). 16 The appearance of 236, 157 and 88 base pair amplification products corresponding to C. pneumoniae, L. pneumophila and M. pneumoniae, respectively, was considered to be a positive reaction. In each experiment, negative and positive controls for each pathogen were used. Positive controls were made with the PCR-TOPO 2.1 cloning kit (Invitrogen). 
Sensitivity and specificity of the multiplex PCR
Results
Sensitivity and specificity of the multiplex PCR
The reproducibility of the cut-off results was determined by testing duplicates of a 10-fold serial dilution of the positive controls in 10 independent experiments. No significant differences in the sensitivity of each primer set were observed when tested in both the multiplex and monoplex PCR assays. Our multiplex PCR was able to reliably detect 10 copies/100 ml of each of the three pathogen DNAs. We also measured the amount of DNA of the PCR products in each of the three pathogens in 10 independent experiments. Based on the results from average DNA concentrations, we decided the level of semi-quantitation as follows: 10 copies/100 ml indicate þ , 10 2 copies/ 100 ml indicate 2 þ and 10 3 copies/100 ml indicate 3 þ . The specificity of the PCR reaction was considered satisfactory as no specific amplification was noted with any of the tested pathogens.
Analysis of C: pneumoniae; M: pneumoniae and L: pneumophila infections using respiratory samples with CAP Among our 208 CAP cases, the most common pathogens were Streptococcus pneumoniae, found in 52 cases, followed by Haemophilus influenzae in 38 cases, C. pneumoniae in 15 cases, M. pneumoniae in 10 cases, L. pneumophila in eight cases, Staphylococcus aureus in seven cases and Moraxella catarrahalis in five cases by using the conventional methods (culture, serology or antigen detection test). All 15 cases of C. pneumoniae demonstrated four-fold or greater rises in IgG antibody titers and five cases demonstrated positive IgM antibody titers. No culture-positive patient was observed among these cases. Of the 15 cases, C. pneumoniae was the only pathogen identified in nine cases (60.0%), while one or more additional etiological agents was found in six cases (40.0%). The additional pathogens were S. pneumoniae in two, H. influenzae in two, M. catarrahalis in two and M. pneumoniae in one. Among all the mixed-C. pneumoniae pneumonia cases, one additional agent was found in five cases and two additional agents were found in one case. All 10 cases of M. pneumoniae demonstrated four-fold or greater rises in CF or PA antibody titers. Of the 10 cases, one additional etiological agents was found in three cases (30.0%). The additional pathogens were S. pneumoniae in two and C. pneumoniae in one. Among eight cases of L. pneumophila, all cases demonstrated four-fold or greater rises in antibody titers and one culture-positive patient and two urinary antigen-positive patients were observed. Of the eight cases, one or more additional etiological agents was found in four cases. The additional pathogens were H. influenzae in two, S. pneumoniae in one, M. catarrahalis in one and C. psittaci in one. Among all the mixed-L. pneumophila pneumonia cases, one additional agent was found in three cases and two additional agents were found in one case.
A total of 208 CAP cases were investigated by the multiplex PCR. The multiplex PCR results were concordant with those obtained by conventional methods for the 208 cases, with positive concordant results for 31 cases (13 for C. pneumoniae, nine for M. pneumoniae, one for dual infection with C. pneumoniae and M. pneumoniae and eight for L. pneumophila) and negative concordant results for 165 cases (Table 1) . Discrepant results were observed in 12 cases. An overall agreement of 94.2% with conventional methods was obtained for the 208 cases.
The details of C. pneumoniae, M. pneumoniae and L. pneumophila positive cases using conventional methods and Multiplex PCR results are listed in Table 2 . Of these, only one discrepant result was observed in a patient (patient No. 2) who was serology-positive for C. pneumoniae (four-fold rise in both IgM and IgG antibody titer) but multiplex PCR-negative. In this case, a diagnosis of C. pneumoniae pneumonia was made because of the serological result, the absence of other respiratory pathogens and his response to macrolide. This might suggest that the amount of DNA in this sample was below the detection limit. Dual infection with C. pneumoniae and M. pneumoniae was observed in only one patient (patient No. 15) and the multiplex PCR was also positive in both pathogens.
Among the 208 CAP cases, 11 cases who were the multiplex PCR positive and conventional method negative were observed, one for C. pneumoniae, five for M. pneumoniae, one for dual infection with C. pneumoniae and M. pneumoniae and four for L. pneumophila (Table 3 ). On the basis of bacterial cultures, clinical features and the response to antibiotics, the multiplex PCR results were considered significant in three of these 11 cases (patient No. 3, 9, and 11) . In one other case (patient No. 10), another significant bacterial pathogen was isolated, but on the basis of the response to the prescribed antibiotic, the role of L. pneumophila could not be excluded. Seven other cases had DNA with one of the three atypical pathogens, but all responded to antibiotics not suitable for the treatment of atypical pathogens. Though the PCR results in these seven cases may seem irrelevant, they may simply indicate that in the normal host these infections are self-limiting.
Discussion
The etiologic diagnosis of infections with atypical pathogens such as C. pneumoniae, M. pneumoniae and L. pneumophila still remains difficult. This is mainly due to difficulties in culturing and to the delayed results associated with conventional methods (serology and culturing), which often allow a retrospective diagnosis only. The current development of NAA techniques should offer a highly sensitive, specific and rapid diagnosis of CAP. In this study, we reported the successful development of a multiplex PCR for the simultaneous detection and differentiation of C. pneumoniae, M. pneumoniae and L. pneumophila.
In the experiments performed with clinical specimens, it was possible to test all specimens simultaneously for the presence of nucleic acids from three atypical pathogens with comparatively little effort, thus indicating that this method is well-suited for use in epidemiological studies as well as for rapid microbiological studies in the clinical setting. Tong et al. 10 reported good agreement of a multiplex PCR and conventional methods using a panel of known positive and negative samples for M. pneumoniae, C. pneumoniae and C. psittaci. Of their panel of 53 samples, nine of 11 M. pneumoniae, 11 of 11 C. pneumoniae, six of seven C. psittaci and 24 of 24 negative samples were correctly identified. Welti et al. 13 also reported good agreement of a multiplex real-time PCR and serology using 38 patients with C. pneumoniae, M. pneumoniae or L. pneumophila respiratory tract infections. Of 19 serology-positive patients, 14 were confirmed by the multiplex real-time PCR to be infected by one of the three pathogens. All samples from serology-negative patients were negative with the multiplex realtime PCR. In our study, all but one sample from conventional method positive patients were also positive with the multiplex PCR. In addition, 165 samples from conventional method negative patients were also negative with the multiplex PCR (Table 1 ). Our results are consistent with these reported by Tong et al. 10 and Welti et al. 13 and indicate that the multiplex PCR assay is a useful and rapid diagnostic tool for the management of community-acquired atypical pneumonia. Grondahl et al. 11 reported a multiplex reverse transcription-PCR protocol for detecting up to nine different respiratory agents, including C. pneumoniae and M. pneumoniae, in children. But that 17, 18 This may reflect a specimen choice problem; i.e., nasopharyngeal aspirates versus swabs, as suggested by the same authors. 19 It has been suggested that the sensitivity of PCRs differ when different types of respiratory samples are used and that the highest sensitivity and specificity to diagnose C. pneumoniae, M. pneumoniae and L. pneumophila could be obtained with sputum and broncho alveolar lavage. 20, 21 Therefore, more studies using different types of specimens are needed to evaluate our multiplex PCR assay.
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One of the characteristics of NAAs is their ability to detect non-viable organisms that have not been cleared, especially after antibiotic treatment. 22 Several studies suggest that many cases of CAP with an undetermined etiologic diagnosis are associated with previous antibiotic administration. 23, 24 Thus while antibiotic treatment compromises the chance of bacterial isolation, PCR detection is not affected by the lack of viability of the pathogens and is more sensitive than cultures for the detection of atypical pathogens in respiratory specimens. 10 In contrast, prolonged and asymptomatic shedding of C. pneumoniae and M. pneumoniae has been reported. 17, 18, [25] [26] [27] [28] [29] [30] Therefore, one should be aware that when using a sensitive PCR technique, it is possible to detect a persistent bacterial genome for a prolonged period. In this study, we also analyzed the 11 patients who were multiplex PCR positive but conventional method negative with regard to whether the episode of CAP was caused by the identified organism. Some patients ( Table 3 , No. 3, 9, and 11) responded to initial treatment with the appropriate antibiotic for M. pneumoniae and L. pneumophila and no other significant bacterial pathogens were isolated in these patients. So, the multiplex PCR result was considered significant in these three cases. In contrast, several patients ( Table 3 , No. 1, 2, 4, 5, 6, 7, and 8) were treated with inappropriate antibiotics for atypical pathogens and appeared to have a prolonged or asymptomatic infection. Overall, we believe that in at least four of 11 patients in this series, the finding of M. pneumoniae or L. pneumophila could be clinically relevant.
In conclusion, we have successfully developed a rapid, highly sensitive and specific semi-quantitative multiplex PCR that can simultaneously detect and differentiate three causative agents of atypical pneumonia. To study the usefulness of this assay in a clinical context, it is necessary to carry out prospective studies covering both epidemic and non-epidemic periods, using different types of respiratory samples.
